Loading...
Keywords
Last Name
Institution

Jennifer Goldman

Concepts (263)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anti-Bacterial Agents
26
2021
216
11.080
Why?
Humans
56
2021
5654
3.280
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
5
2021
8
3.250
Why?
Hospitals, Pediatric
8
2021
150
3.050
Why?
Drug-Related Side Effects and Adverse Reactions
5
2021
24
2.930
Why?
Stevens-Johnson Syndrome
7
2020
12
2.720
Why?
Child
35
2021
2466
2.550
Why?
Vancomycin
3
2021
17
2.450
Why?
Trimethoprim
4
2018
7
2.270
Why?
Retrospective Studies
18
2021
953
1.940
Why?
Respiratory Insufficiency
2
2021
14
1.780
Why?
Female
24
2021
3292
1.690
Why?
Cross Infection
3
2019
18
1.630
Why?
Drug Monitoring
2
2020
21
1.590
Why?
Acute Kidney Injury
2
2021
24
1.590
Why?
Adolescent
18
2021
1852
1.540
Why?
Male
22
2021
3212
1.510
Why?
Ambulatory Care
2
2019
35
1.490
Why?
Staphylococcus aureus
3
2016
22
1.440
Why?
Antifungal Agents
2
2017
27
1.380
Why?
Microsomes, Liver
3
2016
38
1.360
Why?
Anti-Infective Agents, Urinary
2
2016
4
1.340
Why?
Anti-Infective Agents
3
2015
18
1.300
Why?
Electronic Health Records
5
2020
47
1.290
Why?
Child, Preschool
15
2021
1443
1.270
Why?
Pediatrics
4
2018
218
1.170
Why?
Pharmacy Service, Hospital
2
2020
8
1.080
Why?
Pharmacovigilance
2
2019
3
1.050
Why?
Ambulatory Care Facilities
3
2020
25
1.050
Why?
Nurse's Role
3
2020
7
1.030
Why?
Severity of Illness Index
2
2021
142
1.020
Why?
Health Care Costs
2
2019
38
1.020
Why?
Streptococcus pneumoniae
2
2019
16
1.010
Why?
Pneumococcal Infections
2
2019
14
1.010
Why?
Drug Utilization
3
2017
15
0.990
Why?
Bacterial Infections
1
2021
27
0.940
Why?
Bacteremia
3
2015
26
0.920
Why?
Methicillin-Resistant Staphylococcus aureus
3
2016
13
0.900
Why?
Hospital Mortality
2
2019
26
0.890
Why?
Risk Factors
6
2021
376
0.860
Why?
Clostridium Infections
1
2019
7
0.850
Why?
Endophthalmitis
1
2019
1
0.840
Why?
Eye Pain
1
2019
1
0.840
Why?
Causality
1
2019
8
0.840
Why?
Infusions, Parenteral
1
2019
5
0.840
Why?
Cefazolin
1
2018
2
0.820
Why?
Penicillins
1
2018
7
0.820
Why?
Patient Readmission
1
2019
63
0.810
Why?
Preoperative Care
1
2018
26
0.810
Why?
Antibiotic Prophylaxis
1
2018
22
0.800
Why?
Emergency Service, Hospital
2
2020
113
0.800
Why?
Guideline Adherence
2
2017
32
0.800
Why?
Intensive Care, Neonatal
1
2019
40
0.790
Why?
Patient Discharge
1
2019
53
0.790
Why?
Arthritis, Juvenile
2
2015
23
0.760
Why?
Glucagon-Like Peptide-1 Receptor
1
2017
1
0.750
Why?
Peptides
1
2017
10
0.740
Why?
Staphylococcal Infections
2
2015
25
0.730
Why?
Education, Pharmacy
1
2017
3
0.730
Why?
Students, Pharmacy
1
2017
3
0.730
Why?
Diabetes Mellitus, Type 2
1
2017
24
0.730
Why?
Home Infusion Therapy
1
2017
2
0.730
Why?
Hypoglycemic Agents
1
2017
26
0.730
Why?
Infusions, Intravenous
1
2017
26
0.720
Why?
Bacterial Typing Techniques
1
2016
4
0.720
Why?
Drug Prescriptions
1
2017
17
0.720
Why?
Staphylococcal Skin Infections
1
2016
3
0.710
Why?
Anthelmintics
1
2016
1
0.710
Why?
Paragonimiasis
1
2016
1
0.710
Why?
Praziquantel
1
2016
1
0.710
Why?
Antiviral Agents
1
2017
29
0.710
Why?
Medicaid
1
2017
24
0.700
Why?
Prospective Studies
4
2021
439
0.690
Why?
Proteins
1
2016
21
0.690
Why?
Eosinophilia
1
2016
23
0.680
Why?
Fluoroquinolones
1
2016
2
0.680
Why?
Hospitalization
2
2019
126
0.670
Why?
Health Knowledge, Attitudes, Practice
1
2017
94
0.670
Why?
Enterococcus faecalis
1
2015
1
0.650
Why?
Neoplasms
1
2017
87
0.650
Why?
Gentamicins
1
2015
6
0.650
Why?
Gram-Positive Bacterial Infections
1
2015
12
0.640
Why?
Gastrointestinal Diseases
1
2016
49
0.640
Why?
Medication Therapy Management
1
2015
8
0.630
Why?
Adult
5
2021
1065
0.620
Why?
Surveys and Questionnaires
5
2020
266
0.620
Why?
Vancomycin Resistance
1
2014
4
0.590
Why?
Biomarkers
3
2014
117
0.550
Why?
Practice Guidelines as Topic
3
2020
102
0.540
Why?
Young Adult
4
2021
526
0.540
Why?
Hot Temperature
1
2012
5
0.510
Why?
Erythema
1
2012
5
0.510
Why?
Enteral Nutrition
1
2012
53
0.490
Why?
United States
9
2020
657
0.460
Why?
Infant
5
2019
1315
0.450
Why?
Adverse Drug Reaction Reporting Systems
2
2021
11
0.450
Why?
Drug Therapy, Combination
2
2021
48
0.450
Why?
Inappropriate Prescribing
3
2020
18
0.440
Why?
Pharmacogenetics
4
2020
109
0.420
Why?
Diagnosis, Differential
2
2019
69
0.380
Why?
Hospital Costs
2
2019
23
0.380
Why?
Program Evaluation
2
2020
48
0.370
Why?
Biotransformation
3
2016
55
0.370
Why?
Venous Thromboembolism
2
2018
11
0.360
Why?
Length of Stay
4
2019
197
0.320
Why?
Age Factors
2
2016
227
0.320
Why?
Infant, Newborn
2
2019
933
0.290
Why?
Hospitals
2
2020
19
0.280
Why?
Cross-Sectional Studies
3
2020
239
0.270
Why?
Respiratory Tract Infections
2
2020
51
0.260
Why?
Pharmaceutical Preparations
2
2020
38
0.240
Why?
Data Collection
2
2020
36
0.240
Why?
Cohort Studies
3
2018
231
0.240
Why?
Leadership
1
2020
5
0.230
Why?
Biological Availability
2
2017
15
0.230
Why?
Safety
1
2020
19
0.220
Why?
Health Services Needs and Demand
1
2020
18
0.220
Why?
Patient Care Team
1
2020
25
0.220
Why?
Communication
1
2020
53
0.220
Why?
Drug Eruptions
1
2019
3
0.220
Why?
Safety Management
2
2020
5
0.220
Why?
Pharmacists
1
2019
3
0.210
Why?
Skin
1
2019
16
0.210
Why?
Inpatients
2
2017
39
0.210
Why?
Nursing Staff, Hospital
1
2020
26
0.210
Why?
Linear Models
1
2019
58
0.210
Why?
Vitrectomy
1
2019
1
0.210
Why?
Acetylcysteine
2
2016
12
0.210
Why?
Outpatient Clinics, Hospital
1
2019
7
0.210
Why?
Probability
1
2019
21
0.210
Why?
Acute Disease
1
2019
59
0.210
Why?
Washington
1
2018
17
0.210
Why?
Drug Hypersensitivity
1
2018
15
0.200
Why?
Time Factors
1
2020
289
0.200
Why?
Drug Utilization Review
2
2015
6
0.200
Why?
General Surgery
1
2018
22
0.200
Why?
Nephrotic Syndrome
1
2018
20
0.200
Why?
Algorithms
1
2019
92
0.200
Why?
Reproducibility of Results
1
2019
176
0.200
Why?
Protein Binding
1
2018
45
0.200
Why?
Drug Interactions
1
2018
33
0.200
Why?
Risk Assessment
1
2019
151
0.200
Why?
Nurses
1
2018
16
0.190
Why?
Expert Testimony
1
2018
6
0.190
Why?
Clinical Trials as Topic
2
2016
62
0.190
Why?
Child, Hospitalized
1
2017
14
0.190
Why?
Documentation
1
2017
2
0.190
Why?
Learning
1
2017
8
0.180
Why?
Nonprescription Drugs
1
2017
4
0.180
Why?
Clindamycin
1
2017
3
0.180
Why?
Insurance Claim Review
1
2017
2
0.180
Why?
Organ Transplantation
1
2017
6
0.180
Why?
Bone Marrow Transplantation
1
2017
23
0.180
Why?
Models, Statistical
1
2017
30
0.180
Why?
Penicillin-Binding Proteins
1
2016
2
0.180
Why?
Soft Tissue Infections
2
2016
9
0.180
Why?
Self Efficacy
1
2017
33
0.180
Why?
Reagent Kits, Diagnostic
1
2016
12
0.180
Why?
Education, Nursing, Continuing
1
2016
2
0.180
Why?
Practice Patterns, Nurses'
1
2016
4
0.180
Why?
Pediatric Nurse Practitioners
1
2016
4
0.180
Why?
Nalidixic Acid
1
2016
1
0.170
Why?
DNA Gyrase
1
2016
1
0.170
Why?
Topoisomerase II Inhibitors
1
2016
1
0.170
Why?
Opportunistic Infections
1
2016
8
0.170
Why?
Drug Resistance, Bacterial
1
2016
14
0.170
Why?
Sensitivity and Specificity
1
2016
141
0.170
Why?
Child Health Services
1
2016
32
0.170
Why?
Obesity
1
2017
91
0.170
Why?
Dose-Response Relationship, Drug
1
2016
105
0.160
Why?
Hospitalists
1
2015
7
0.160
Why?
Drug Resistance, Microbial
1
2015
9
0.160
Why?
Methylation
1
2015
17
0.160
Why?
In Vitro Techniques
1
2015
30
0.160
Why?
Oxidation-Reduction
1
2015
28
0.160
Why?
Congresses as Topic
3
2020
11
0.160
Why?
Microbial Sensitivity Tests
1
2014
35
0.140
Why?
Personality Disorders
1
2013
4
0.140
Why?
Schizophrenia
1
2013
5
0.140
Why?
Social Behavior
1
2013
13
0.140
Why?
Animals
1
2016
866
0.140
Why?
Motivation
1
2013
61
0.140
Why?
Diarrhea
1
2012
12
0.140
Why?
Vomiting
1
2012
23
0.130
Why?
Nod2 Signaling Adaptor Protein
1
2012
3
0.130
Why?
Crohn Disease
1
2012
18
0.130
Why?
Gastric Bypass
1
2012
6
0.130
Why?
Gastroparesis
1
2012
5
0.130
Why?
Folic Acid
1
2011
13
0.130
Why?
Reference Values
1
2011
41
0.130
Why?
Methotrexate
1
2011
18
0.130
Why?
Aging
1
2011
38
0.120
Why?
Genotype
1
2011
283
0.120
Why?
Appendectomy
1
2012
101
0.110
Why?
Appendicitis
1
2012
118
0.110
Why?
Translational Medical Research
2
2020
6
0.100
Why?
International Cooperation
2
2020
9
0.100
Why?
Incidence
2
2019
126
0.100
Why?
Databases, Factual
2
2020
97
0.100
Why?
Aged
2
2018
292
0.080
Why?
Outpatients
1
2020
13
0.060
Why?
Global Health
1
2020
12
0.060
Why?
Computer Communication Networks
1
2020
2
0.060
Why?
Liver Function Tests
1
2019
5
0.060
Why?
Antipsychotic Agents
1
2019
5
0.060
Why?
Canada
1
2020
33
0.060
Why?
Europe
1
2020
32
0.060
Why?
Anti-Inflammatory Agents
1
2019
14
0.050
Why?
Registries
1
2020
75
0.050
Why?
Anticonvulsants
1
2019
23
0.050
Why?
Administration, Cutaneous
1
2019
7
0.050
Why?
Patient Safety
1
2020
28
0.050
Why?
Practice Patterns, Physicians'
1
2020
89
0.050
Why?
Attitude of Health Personnel
1
2020
89
0.050
Why?
North America
1
2018
43
0.050
Why?
Immunoglobulins, Intravenous
1
2018
7
0.050
Why?
Intensive Care Units
1
2018
19
0.050
Why?
Logistic Models
1
2018
94
0.050
Why?
Steroids
1
2018
14
0.050
Why?
Survival Analysis
1
2018
51
0.050
Why?
Prevalence
1
2018
131
0.050
Why?
Hospital Charges
1
2018
12
0.050
Why?
Interdisciplinary Communication
1
2018
14
0.050
Why?
Cost of Illness
1
2018
16
0.050
Why?
Early Diagnosis
1
2018
33
0.050
Why?
Health Resources
1
2018
21
0.050
Why?
National Institutes of Health (U.S.)
1
2017
4
0.050
Why?
Delphi Technique
1
2017
9
0.050
Why?
Orosomucoid
1
2017
1
0.050
Why?
Serum Albumin
1
2017
9
0.050
Why?
Injections, Intravenous
1
2017
23
0.050
Why?
Bayes Theorem
1
2017
16
0.050
Why?
Consensus
1
2017
29
0.050
Why?
Area Under Curve
1
2017
55
0.050
Why?
Drug Dosage Calculations
1
2017
18
0.040
Why?
Drug Administration Schedule
1
2017
50
0.040
Why?
Otitis Media
1
2016
2
0.040
Why?
Pregnancy
1
2018
251
0.040
Why?
Sinusitis
1
2016
4
0.040
Why?
Body Weight
1
2017
62
0.040
Why?
Pharyngitis
1
2016
11
0.040
Why?
Body Mass Index
1
2017
111
0.040
Why?
Hospital Bed Capacity
1
2016
3
0.040
Why?
Urinary Tract Infections
1
2016
23
0.040
Why?
Quality Improvement
1
2016
52
0.040
Why?
Virulence Factors
1
2015
4
0.040
Why?
C-Reactive Protein
1
2015
12
0.040
Why?
Hemoglobins
1
2015
23
0.040
Why?
Treatment Outcome
1
2018
586
0.040
Why?
Chromatography, Liquid
1
2014
11
0.040
Why?
Tandem Mass Spectrometry
1
2014
24
0.040
Why?
Schizophrenic Psychology
1
2013
3
0.040
Why?
Mood Disorders
1
2013
6
0.040
Why?
Psychiatric Status Rating Scales
1
2013
15
0.040
Why?
Self Report
1
2013
32
0.030
Why?
ROC Curve
1
2012
20
0.030
Why?
Case-Control Studies
1
2012
104
0.030
Why?
Polymerase Chain Reaction
1
2012
98
0.030
Why?
Enzymes
1
2011
4
0.030
Why?
Drug Therapy
1
2011
7
0.030
Why?
Middle Aged
1
2013
561
0.030
Why?
Carrier Proteins
1
2011
33
0.030
Why?
Cytochrome P-450 Enzyme System
1
2011
81
0.030
Why?
Goldman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description